Clinical Trial

A Safety Study of Contralateral Eye Dosing of VGR-R01 in Participants With Bietti's Crystalline Dystrophy (BCD)

Name: A Safety Study of Contralateral Eye Dosing of VGR-R01 in Participants With Bietti's Crystalline Dystrophy (BCD) — clinical trial record (NCT07586306)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

This is a multi-centre, single- arm, non-randomized, open-label phase 1/2 clinical trial which enables dosing of the fellow eyes of patients who received VGR-R01 administration in previous studies.

Trial Details

NCT Number	NCT07586306
Lead Sponsor	Shanghai Vitalgen BioPharma Co., Ltd.
Conditions	Bietti Crystalline Dystrophy
Enrollment	15 participants
Start Date	2026-06-01
Primary Completion	2027-07-31 (estimated)
Study Completion	2031-07-31 (estimated)
Updated on ClinicalTrials.gov	2026-05-14